Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Recher

Showing results (21-30 of 136) with videos related to

Pageof 14
Sort By:
BMC Cancer|October 27, 2015
Ambulatory Medical Assistance--After Cancer (AMA-AC): A model for an early trajectory survivorship survey of lymphoma patients treated with anthracycline-based chemotherapyGisèle Compaci, Manuela Rueter, Sébastien Lamy, et al.
Journal of Contemporary Brachytherapy|February 23, 2023
Brachytherapy for uterine cervix-limited acute myeloid leukemia relapseGuillaume Beziat, Suzanne Tavitian, Francois-Xavier Arnaud, et al.
Blood|July 16, 2005
Tumor necrosis factor-alpha inhibits hTERT gene expression in human myeloid normal and leukemic cellsOdile Beyne-Rauzy, Naïs Prade-Houdellier, Cécile Demur, et al.
Cancer Research|October 22, 2009
Constitutive activation of the DNA damage signaling pathway in acute myeloid leukemia with complex karyotype: potential importance for checkpoint targeting therapyCindy Cavelier, Christine Didier, Naïs Prade, et al.
Blood|June 26, 2012
Long-term outcome of higher-risk MDS patients treated with azacitidine: an update of the GFM compassionate program cohortRaphael Itzykson, Sylvain Thépot, Bruno Quesnel, et al.
Blood|May 22, 2009
Polo-like kinase 1 is overexpressed in acute myeloid leukemia and its inhibition preferentially targets the proliferation of leukemic cellsAnnelies G Renner, Cédric Dos Santos, Christian Recher, et al.
Blood|June 5, 2009
The new tyrosine-kinase inhibitor and anticancer drug dasatinib reversibly affects platelet activation in vitro and in vivoMarie-Pierre Gratacap, Valérie Martin, Marie-Cécile Valéra, et al.
Haematologica|June 29, 2014
Anthracycline dose intensification improves molecular response and outcome of patients treated for core binding factor acute myeloid leukemiaThomas Prebet, Sarah Bertoli, Jacques Delaunay, et al.
Oncogene|August 25, 2004
Tumor necrosis factor alpha induces senescence and chromosomal instability in human leukemic cellsOdile Beyne-Rauzy, Christian Recher, Nicole Dastugue, et al.
Plos One|February 4, 2012
Optical imaging of disseminated leukemia models in mice with near-infrared probe conjugated to a monoclonal antibodySabrina Pesnel, Arnaud Pillon, Laurent Créancier, et al.
Pageof 14

Showing results (21-30 of 136) with videos related to

Sort By:
Pageof 14
BMC Cancer|October 27, 2015
Ambulatory Medical Assistance--After Cancer (AMA-AC): A model for an early trajectory survivorship survey of lymphoma patients treated with anthracycline-based chemotherapyGisèle Compaci, Manuela Rueter, Sébastien Lamy, et al.
Journal of Contemporary Brachytherapy|February 23, 2023
Brachytherapy for uterine cervix-limited acute myeloid leukemia relapseGuillaume Beziat, Suzanne Tavitian, Francois-Xavier Arnaud, et al.
Blood|July 16, 2005
Tumor necrosis factor-alpha inhibits hTERT gene expression in human myeloid normal and leukemic cellsOdile Beyne-Rauzy, Naïs Prade-Houdellier, Cécile Demur, et al.
Cancer Research|October 22, 2009
Constitutive activation of the DNA damage signaling pathway in acute myeloid leukemia with complex karyotype: potential importance for checkpoint targeting therapyCindy Cavelier, Christine Didier, Naïs Prade, et al.
Blood|June 26, 2012
Long-term outcome of higher-risk MDS patients treated with azacitidine: an update of the GFM compassionate program cohortRaphael Itzykson, Sylvain Thépot, Bruno Quesnel, et al.
Blood|May 22, 2009
Polo-like kinase 1 is overexpressed in acute myeloid leukemia and its inhibition preferentially targets the proliferation of leukemic cellsAnnelies G Renner, Cédric Dos Santos, Christian Recher, et al.
Blood|June 5, 2009
The new tyrosine-kinase inhibitor and anticancer drug dasatinib reversibly affects platelet activation in vitro and in vivoMarie-Pierre Gratacap, Valérie Martin, Marie-Cécile Valéra, et al.
Haematologica|June 29, 2014
Anthracycline dose intensification improves molecular response and outcome of patients treated for core binding factor acute myeloid leukemiaThomas Prebet, Sarah Bertoli, Jacques Delaunay, et al.
Oncogene|August 25, 2004
Tumor necrosis factor alpha induces senescence and chromosomal instability in human leukemic cellsOdile Beyne-Rauzy, Christian Recher, Nicole Dastugue, et al.
Plos One|February 4, 2012
Optical imaging of disseminated leukemia models in mice with near-infrared probe conjugated to a monoclonal antibodySabrina Pesnel, Arnaud Pillon, Laurent Créancier, et al.
Pageof 14